# Immune Diseases

## 0. Reviews

* ✅  **\[review] 2023 Nature Reviews Rheumatology** - Precision medicine in systemic lupus erythematosus
* ✅  **\[review] 2023 Nature Reviews Rheumatology** - Post-transcriptional checkpoints in autoimmunity&#x20;
* **\[review] 2022 Nature Reviews Rheumatology** - The role of mitochondria in rheumatic diseases

## I. Genetics & post-GWAS analysis

* ✅ \[review] **2023 Nature Reviews Nephrology** - Genetics of SLE: mechanistic insights from monogenic disease and disease-associated variants
* **2020 Genome Biology** - Human A-to-I RNA editing SNP loci are enriched in GWAS signals for autoimmune diseases and under balancing selection
* **2019 Nature Communications** - SLE non-coding genetic risk variant determines the epigenetic dysfunction of an immune cell speciﬁc enhancer that controls disease-critical microRNA expression

## II. scRNA

* [**2022 **_**Signal transduction and targeted therapy**_](https://www.nature.com/articles/s41392-022-01167-9) - Deciphering transcriptome alterations in bone marrow hematopoiesis at single-cell resolution in immune thrombocytopenia
* ✅ [**2022 **_**Science**_](https://pubmed.ncbi.nlm.nih.gov/35389781/) - Single-cell RNA-seq reveals cell type–specific molecular and genetic associations to lupus
* ✅ [**2022 **_**Cell**_](https://www.sciencedirect.com/science/article/pii/S0092867422009242) _**-**_ Distinct transcriptome architectures underlying lupus establishment and exacerbation
* ✅ [**2021 **_**Cell**_ ](https://pubmed.ncbi.nlm.nih.gov/33930287/)- Dynamic landscape of immune cell-specific gene regulation in immune-mediated diseases
* [**2022 Nature Med**](https://www.nature.com/articles/s41591-022-01789-0) - Rituximab versus tocilizumab in rheumatoid arthritis: synovial biopsy-based biomarker analysis of the phase 4 R4RA randomized trial
* 2021 PNAS - The dynamic epigenetic regulation of the inactive X chromosome in healthy human B cells is dysregulated in lupus patients
* **2020 Nature Immunology** - Mapping systemic lupus erythematosus heterogeneity at the single-cell level
* [**2019 **_**Nature**_](https://pubmed.ncbi.nlm.nih.gov/31554970/) - Analysis of the B cell receptor repertoire in six immune-mediated diseases

## III. scMulti-Omics

* **2023 Nature cell biology** - Single-cell analysis reveals transcriptomic and epigenomic impacts on the maternal– fetal interface following SARS-CoV-2 infection
* [**2022 **_**Cell Reports**_](https://pubmed.ncbi.nlm.nih.gov/36351407/) - Single-cell transcriptome profiling and chromatin accessibility reveal an exhausted regulatory CD4+ T cell subset in systemic lupus erythematosus
* **2021 Science Immunology** - Integrated single-cell transcriptomics and epigenomics reveals strong germinal center–associated etiology of autoimmune risk loci
* **2021 Nature Genetics** - Single-cell chromatin accessibility identifies pancreatic islet cell type– and state-specific regulatory programs of diabetes risk

## IV. CART-T

* **2022 Nature Leukemia** - Single-cell ATAC-seq maps the comprehensive and dynamic chromatin accessibility landscape of CAR-T cell dysfunction

## V. Biomarkers

* (SLE biomarker) [_**2022 Lancet Rheumatol**_](https://www.sciencedirect.com/science/article/pii/S2665991322003320?via%3Dihub) - Identification of biomarkers to stratify response to B-cell-targeted therapies in systemic lupus erythematosus: an exploratory analysis of a randomised controlled trial

